Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

by Ashley P. Taylor

Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.

by Marci A. Landsmann

National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.

by Marci A. Landsmann

The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?

by Brad Jones

Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.

by Anna Azvolinsky

The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.

by Marci A. Landsmann

The STAR Act passes in the U.S. House of Representatives.

by Brad Jones

Medical oncologists discuss marijuana with their patients. Many of these doctors feel they aren't well enough informed to make recommendations about it, but some do anyway.

by Kate Yandell

A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.

by Brad Jones

At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

by Kate Yandell